Efficacy and Safety of Bimekizumab in Psoriatic Arthritis Patients with Significant Skin and Nail Involvement Over One Year - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Efficacy and Safety of Bimekizumab in Psoriatic Arthritis Patients with Significant Skin and Nail Involvement Over One Year

  • By

  • Diamant Thaçi

  • Akihiko Asahina

  • Wolf-Henning Boehncke

  • Alice B. Gottlieb

  • Mark Lebwohl

  • Richard B. Warren

  • Heather Edens

  • Barbara Ink

  • Rajan Bajracharya

  • Jason Coarse

  • Joseph F. Merola

  • December 12, 2025

Share

  • 1

    Bimekizumab significantly improved disease symptoms in PsA patients with skin and nail involvement compared to placebo at week 16.

  • 2

    Improvements in disease domains with bimekizumab were sustained through week 52 for both biologic-naïve and TNFi-IR patients.

  • 3

    The treatment was well tolerated, with no new safety concerns identified during the study.

  • 4

    Bimekizumab's efficacy in treating PsA with concomitant plaque-type psoriasis and nail involvement is clinically relevant.

  • 5

    This study provides valuable data for clinicians in selecting effective treatments for patients with severe PsA symptoms.

Original Source(s)

Efficacy and Safety of Bimekizumab in Psoriatic Arthritis Patients with Significant Skin and Nail Involvement Over One Year

  • by Diamant Thaçi, Akihiko Asahina, Wolf-Henning Boehncke, Alice B. Gottlieb, Mark Lebwohl, Richard B. Warren, Heather Edens, Barbara Ink, Rajan Bajracharya, Jason Coarse, Joseph F. Merola

  • December 12, 2025

Related Content

Spondyloarthritis function varies by sex

Women had greater functional deterioration over 17 years, while permanent work disability did not differ significantly between sexes.

Longitudinal Performance of the Psoriasis Epidemiology Screening Tool (PEST) in Canada and Latin America: Results from the Prospective, Observational, 5-Year PURE Registry

Reanalysis of the immunological characteristics of scalp psoriasis: a cross-sectional study using Olink proteomics